MHRA Includes Device Regulatory Goals in Pre-Brexit Work Plan
The U.K.’s Medicines and Healthcare products Regulatory Agency laid out its top 10 priorities for 2017 and 2018 — including developing a model for the agency’s future, post-Brexit.
The MHRA is planning to propose a five-year plan encompassing national and international strategies for collaboration, as well as a model for the future regulation of the country’s medical products after leaving the European Union.
Regarding the EU’s new medical device and in vitro diagnostic regulations, the MHRA plans to revise its processes by the end of the fourth quarter. Other major goals include securing global supply chains for medical devices.
The agency also plans to help expand the International Medical Device Regulators Forum with new working groups — and establish a separate working group of European regulators to develop a consistent approach to combination products.